Growth Metrics

Emergent BioSolutions (EBS) EPS (Basic) (2016 - 2026)

Emergent BioSolutions has reported EPS (Basic) over the past 17 years, most recently at $0.13 for Q1 2026.

  • For Q1 2026, EPS (Basic) fell 89.6% year-over-year to $0.13; the TTM value through Mar 2026 reached -$0.14, up 94.49%, while the annual FY2025 figure was $0.98, 127.22% up from the prior year.
  • EPS (Basic) for Q1 2026 was $0.13 at Emergent BioSolutions, up from -$1.01 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $2.16 in Q3 2024 and troughed at -$5.38 in Q2 2024.
  • A 5-year average of -$1.27 and a median of -$0.88 in 2023 define the central range for EPS (Basic).
  • Biggest five-year swings in EPS (Basic): crashed 10500.0% in 2022 and later surged 635.29% in 2025.
  • Year by year, EPS (Basic) stood at -$1.34 in 2022, then surged by 34.33% to -$0.88 in 2023, then soared by 35.23% to -$0.57 in 2024, then tumbled by 77.19% to -$1.01 in 2025, then skyrocketed by 112.87% to $0.13 in 2026.
  • Business Quant data shows EPS (Basic) for EBS at $0.13 in Q1 2026, -$1.01 in Q4 2025, and $0.96 in Q3 2025.